Contenido Relacionado

Contenido en el Idioma Español de University of Maryland Medical Center

Niacina - Side Effects

Nombres alternativos

Ácido nicotínico; Vitamina B3

Efectos secundarios:

Una deficiencia de niacina causa pelagra y los síntomas son, entre otros:

Problemas digestivos.
Inflamación de la piel.
Deterioro mental.

Las dosis altas de niacina pueden causar:

Aumento del nivel de azúcar (glucosa) en la sangre.
Daño hepático.
Úlcera péptica.
Erupción cutánea.

Incluso dosis normales pueden estar asociadas con enrojecimiento de la piel. Las nuevas formas del ácido nicotínico reducen este efecto secundario. La nicotinamida no causa estos efectos secundarios.

Beneficios de la vitamina B3

Déficit de vitamina B3

Fuentes de vitamina B3

Reviewed last on: 2/14/2011
Alison Evert, MS, RD, CDE, Nutritionist, University of Washington Medical Center Diabetes Care Center, Seattle, Washington. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

Referencias

Escott-Stump S, ed. Nutrition and Diagnosis-Related Care. 6th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2008.

Sarubin Fragaakis A, Thomson C. The Health Professional's Guide to Popular Dietary Supplements. 3rd ed. Chicago, Il: American Dietetic Association; 2007.

Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, PantothenicAcid, Biotin, and Choline. National Academy Press, Washington, DC, 1998.

Cervantes-Laurean D, McElvaney NG, Moss J. Niacin. In: Shils ME, Olson JA, Shike M, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, Md. Williams & Wilkins; 1999:401-411.

Malik S, Kashyap ML. Niacin, lipids, and heart disease. Curr Cardiol Rep. 2003;5:470-476.

McKenny J. New perspectives on the use of niacin in the treatment of lipid disorders. Arch Intern Med; 2004;164:697-705.

Grundy SM, Vega GL, McGovern ME, et al. Efficacy, safety, tolerability of once-daily niacin for the treatmetn of dyslipidemia associated with type 2 diabetes control and evaluation and efficiency of Niaspan trial. Arch Intern Med. 2002;162:1568-1576.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

Connect with UMMC

© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885